samedan logo
 
 
spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

World Meeting

8-11 February 2021
Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.

The entire spectrum of topics, ranging from engineering aspects during the manufacturing process, the portfolio of commercially available excipients enabling formulation of a large variety of medicinal products, the underlying physico-chemical principles, cutting-edge characterization techniques as well as potential pitfalls and hurdles to be overcome during product development, manufacturing and characterisation will be addressed.

The conference will be held on 3.5 days: From Monday (noon) until Thursday (evening). From Tuesday to Thursday, 4 parallel sessions with oral presentations will be held:
— 2 sessions on industry-related topics, presented by distinguished invited speakers, giving overviews on the current state of the art in the respective fields,
— 2 sessions with short talks selected from submitted abstracts, presenting the latest research findings in the broad field of Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Highlights of the scientific programme:
Key note lecture
Engineering cancer immunotherapy - David J. Mooney, Harvard School of Engineering and Applied Sciences, Cambridge, USA

Hot topic lectures
Digitalisation and application of Pharma 4.0 tools to manufacturing - Patrick Hyett, GlaxoSmithKline, United Kingdom Biodegradable drug delivery systems - Steven Schwendeman, College of Pharmacy, University of Michigan Ann Arbor, MI, USA
Delivery of cannabinoids to and across the skin - Elka Touitou, Hebrew University of Jerusalem, Israel

Plenary lectures
Advances in nanotechnology - Patrick Couvreur, Faculty of Pharmaceutical Sciences, Paris Sud University, France Pharmacomicrobiomics: drugs meet the human microbiome - Christina Moissl-Eichinger, Medical University of Graz, Austria
Oral drug delivery systems: from irrelevance to top-selling products and ongoing challenges - Andrea Gazzaniga, Biopharmaceuticals and Pharmaceutical Technology Laboratory, University of Milan, Italy

During the entire conference, the accompanying exhibition ResearchPharm® provides a cross-disciplinary platform for pharmaceutical scientists working in all fields of drug development in industry, academia and regulatory bodies. This exhibition is steadily growing and offers the possibility to present and learn about the newest trends and products in the area of pharmaceutical ingredients, developing and processing equipment, analytical technologies, medicinal products, medical devices and contract manufacturing.

In addition, young and experienced scientists from academia and industry will present their latest research achievements in the form of posters, allowing for fruitful exchanges with the authors.

The meeting is intended to bring together people working in fundamental and applied academic research, chemical and pharmaceutical industry and the regulatory field, offering the opportunity to initiate fruitful discussions and collaborations.

The organizing committee cordially invites you to join the 12th PBP World Meeting and would be glad to welcome you in Vienna, Austria!
phone ++49/6131/9769-0
email info@worldmeeting.org
web www.worldmeeting.org/home/
 
Print this page
Send to a friend
   
spacer

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>


News and Press Releases

Nemera reinforces its value proposition with a refreshing visual identity

At Nemera, we have been successfully providing high quality drug delivery device solutions to our customers and patients for years. We design and manufacture devices with the ultimate goal to improve patient outcomes and experience.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement